bryostatin
Jump to navigation
Jump to search
Indications
- investigational agent for treatment of Alzheimer's disease
Dosage
- 20 ug IV
Mechanism of action
- modulates protein kinase C-epsilon
- effects on neurons
- enhances synaptogenesis
- inhibits apoptosis
- reduces formation of beta-amyloid
- inhibits phosporylation of tau
Notes
- isolated from the marine bryozoan Bugula neritina
More general terms
References
- ↑ Fiore K Bryozoan Compound Tolerated in Alzheimer's Safety Study - Bryostatin may preserve cognitive function, but more studies needed MedPage Today. July 20, 2017. https://www.medpagetoday.com/MeetingCoverage/AAIC/66785